Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00013390 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Treatment Methods for Clinically Significant Tinnitus
A Phase 2 study of Tinnitus, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT00013390 is a Phase 2 study of Tinnitus that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 200 participants, below the 12,611-participant average among 24 other Tinnitus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00013390, a Phase 2 study of Tinnitus, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose to evaluate two different approaches to the alleviation of tinnitus symptoms by comparing changes from baseline performance on the Tinnitus Severity Index. They propose to provide an unbiased evaluation of competing methodologies. The design is one in which pairs of prospective subjects are randomly assigned to one of two treatment groups. Changes in group performance will be compared for selected measures.
Conditions Studied
Interventions
- PROCEDURE Tinnitus Masking
- PROCEDURE Tinnitus Retraining Therapy
Study Locations (1)
Oregon
- VA Medical Center, Portland - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 1999-10 |
| Est. Completion | 2002-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00013390
The ClinicalTrials.gov registry entry for NCT00013390 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,611-participant average among 24 other Tinnitus trials with a reported enrollment target (98% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tinnitus appearing as the primary indexed condition, and to 2 interventions - of which Tinnitus Masking is the first listed.
NCT00013390 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT00013390 about?
NCT00013390 is a clinical study titled "Evaluation of Treatment Methods for Clinically Significant Tinnitus". The investigators propose to evaluate two different approaches to the alleviation of tinnitus symptoms by comparing changes from baseline performance on the Tinnitus Severity Index. They propose to provide an unbiased evaluation of competing methodologies. The design is one in which pairs of prospec...
What is the current status of trial NCT00013390?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 1999-10. Estimated completion is 2002-09.
What conditions does trial NCT00013390 study?
This clinical trial studies the following conditions: Tinnitus.
What interventions are being tested in trial NCT00013390?
The interventions under investigation include: Tinnitus Masking (PROCEDURE), Tinnitus Retraining Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00013390?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00013390 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinnitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial
COMPLETED · Phase 2
-
Zinc to Treat Tinnitus in the Elderly
COMPLETED · Phase 2
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation
RECRUITING · NA
-
Somatosensory Tinnitus RCT
RECRUITING · NA
-
An fMRI Investigation of the Effects of IV Lidocaine on Tinnitus
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.